Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)
CNY 21.29
(-1.25%)
CNY 21.29
(-1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.93 Million | -5.81 Million | 59.94 Million | 73.38 Million | 97.27 Million | 77.21 Million |
| Net Income | 36.31 Million | 32.12 Million | 284.83 Million | 54.52 Million | 97.15 Million | 83.22 Million |
| Depreciation & Amortization | 53.55 Million | 48.14 Million | 37.06 Million | 31.55 Million | 27.68 Million | 16.76 Million |
| Deferred income taxes | -8.46 Million | -28.45 Million | 38.08 Million | -2.62 Million | -558.84 Thousand | 948.46 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -72.85 Million | -102.45 Million | 34.31 Million | -23.17 Million | -36.78 Million | -27.66 Million |
| Other non-cash items | 195.34 Million | 16.36 Million | -296.26 Million | 10.48 Million | 9.21 Million | 4.88 Million |
| Investing Cash Flow | -137.26 Million | 29.11 Million | -85.56 Million | -129.6 Million | -22.68 Million | -103.75 Million |
| Investments in PPE | -197.22 Million | -218.94 Million | -94.41 Million | -120.1 Million | -43.36 Million | -76.67 Million |
| Acquisitions | 648.19 Thousand | 77.07 Thousand | 40.9 Thousand | 120.28 Million | 43.38 Million | 76.78 Million |
| Investment purchases | -23 Million | -230 Million | -48.5 Million | -62 Million | -42 Million | -499.47 Million |
| Sales/Maturities of investments | 82.3 Million | 477.98 Million | 57.3 Million | 52.32 Million | 62.65 Million | 472.27 Million |
| Other Investing Activities | 59.95 Million | 0.43 | 0.16 | -120.1 Million | -43.36 Million | -76.67 Million |
| Financing Cash Flow | 65.07 Million | -42.03 Million | 37.08 Million | 9.01 Million | -25.46 Million | 52.72 Million |
| Debt repayment | -42.15 Million | -286 Million | -135 Million | -129 Million | -115.5 Million | -43.1 Million |
| Dividends payments | -6.46 Million | -30 Million | -15 Million | -30 Million | -24 Million | -24.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 22.91 Million | 279.46 Million | 194.09 Million | 174.99 Million | 119.99 Million | 119.99 Million |
| Accounts receivables | -31.51 Million | -121.75 Million | -37.39 Million | -1.25 Million | -31.61 Million | -14.7 Million |
| Accounts payables | -19.33 Million | 57.12 Million | 16.15 Million | -20.38 Million | 9.32 Million | 27.75 Million |
| Inventory | -22 Million | -9.37 Million | 17.48 Million | 1.09 Million | -13.93 Million | -41.66 Million |
| Other working capital | -27.79 Million | -28.45 Million | 38.08 Million | -2.62 Million | -558.84 Thousand | 14 Million |
| Cash at beginning of period | 95.06 Million | 113.79 Million | 102.4 Million | 149.58 Million | 100.45 Million | 74.27 Million |
| Cash at end of period | 46.82 Million | 95.06 Million | 113.79 Million | 102.4 Million | 149.58 Million | 100.45 Million |
| Capital Expenditure | -197.22 Million | -218.94 Million | -94.41 Million | -120.1 Million | -43.36 Million | -76.67 Million |
| Effect of forex changes on cash | 16.64 Thousand | 8267.66 | -60.94 Thousand | 13.94 Thousand | 3955.31 | 1311.88 |
| Net cash flow / Change in cash | -48.24 Million | -18.72 Million | 11.39 Million | -47.18 Million | 49.13 Million | 26.18 Million |
| Free Cash Flow | -173.28 Million | -224.76 Million | -34.46 Million | -46.71 Million | 53.91 Million | 538.34 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.38 Million | 11.37 Million | 13.35 Million | 13.89 Million | 36.31 Million | 2.94 Million |
| Depreciation & Amortization | - | 13.03 Million | 13.03 Million | 13.54 Million | 53.55 Million | -26.42 Million |
| Deferred income taxes | - | - | - | - | -8.46 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 42.88 Million | - | -53.52 Million | -72.85 Million | 32.39 Million |
| Other non-cash items | 3.93 Million | 33.61 Million | -8.67 Million | 4.11 Million | 195.34 Million | 4.27 Million |
| Investing Cash Flow | -15.98 Million | -14.25 Million | -29.31 Million | -57.1 Million | -137.26 Million | -52.28 Million |
| Investments in PPE | -15.98 Million | -14.25 Million | -29.31 Million | -57.27 Million | -197.22 Million | -53.29 Million |
| Acquisitions | 2002.00 | 3390.00 | - | 169.83 Thousand | 648.19 Thousand | - |
| Investment purchases | -1 Million | - | - | -1 Million | -23 Million | -1 Million |
| Sales/Maturities of investments | 1 Million | - | - | 1 Million | 82.3 Million | 2 Million |
| Other Investing Activities | 3810.22 | 3390.00 | - | 171.88 Thousand | 59.95 Million | 0.47 |
| Financing Cash Flow | 4.26 Million | 5.03 Million | -2.3 Million | 27.02 Million | 65.07 Million | 18.09 Million |
| Debt repayment | -13.6 Million | -10.65 Million | -450 Thousand | -5.39 Million | -42.15 Million | -20.45 Million |
| Dividends payments | -2.06 Million | -7.91 Million | -1.85 Million | -1.8 Million | -6.46 Million | -1.61 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.27 Million | 15.68 Million | -1.85 Million | 32.41 Million | 22.91 Million | 40.15 Million |
| Accounts receivables | - | 55.32 Million | - | -31.51 Million | -31.51 Million | 17.59 Million |
| Accounts payables | - | - | - | - | -19.33 Million | - |
| Inventory | - | -12.43 Million | - | -22 Million | -22 Million | 14.8 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 42.6 Million | 19.87 Million | 46.82 Million | 72.44 Million | 95.06 Million | 93.45 Million |
| Cash at end of period | 38.19 Million | 42.6 Million | 19.87 Million | 46.82 Million | 46.82 Million | 72.44 Million |
| Capital Expenditure | -15.98 Million | -14.25 Million | -29.31 Million | -57.27 Million | -197.22 Million | -53.29 Million |
| Effect of forex changes on cash | 3652.07 | 741.97 | -6276.71 | 9117.07 | 16.64 Thousand | -10.29 Thousand |
| Net cash flow / Change in cash | -4.4 Million | 22.72 Million | -26.94 Million | -25.62 Million | -48.24 Million | -21.01 Million |
| Free Cash Flow | -8.67 Million | 17.69 Million | -24.63 Million | -52.82 Million | -173.28 Million | -40.09 Million |
ASC
BIAFW
000679
XFLS
SNST
BZ